Your search for ‘Hyman, Phelps, & McNamara’ returned 249 results

Were the Drug Enforcement Administration ("DEA") a rock band, it might promote the upcoming National Prescription Drug Take Back Day by setting the lyrics above to a catchy tune.

On October 9, 2025, the U.S. Senate voted in favor of including a revised version of the BIOSECURE Act as an amendment to the National Defense Authorization Act (NDAA).

The Winter Solstice, signifying the shortest day of the year, was Saturday, December 21. Although the earliest sunset of the year was actually in early December...

FDA wants to capitalize on the talent of venture capital (VC) firms that are developing innovative solutions that can be applied to FDA's public health mission. On December 17, 2025...

Drug Enforcement Administration ("DEA") civil monetary settlements involving listed chemicals that do not include pseudoephedrine are rare.

On November 8, 2024, FDA issued a proposed order to remove the oral decongestant ingredient phenylephrine (including both phenylephrine hydrochloride and phenylephrine bitartrate)...

"An open foe may prove a curse, but a pretended friend is worse." When the poet John Gay wrote these words in 1727, the idea of an administrative agency like the FDA...

We recently blogged on FDA's draft guidance, Chemical Analysis for Biocompatibility Assessment of Medical Devices, which describes chemical characterization methods that may be used to demonstrate biocompatibility of a medical device as an alternative to conducting certain biological testing.

Among the more interesting developments in the recent election was the emergency of Robert Kennedy as a prominent figure in the MAGA movement...

The recent and drastic Reduction In Force (RIF) at the U. S. Food and Drug Administration (FDA) is already having ripple effects not just internally...

Last week, DEA and DOJ announced a $59 million civil penalty settlement with eBay related to the failure to comply with Controlled Substances Act (CSA) requirements for identifying purchasers...

While this author needs no excuse to listen to Van Halen, one surprising source of inspiration came while reviewing the body of guidance documents issued by CDRH in the last year.

Every parent is familiar with the parade of horrors that accompany household items as mundane as window coverings.

The word unprecedented has been used a lot in the past two weeks. Perhaps appropriately.

On March 18, 2025, the U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) launched a significant initiative called Operation Stork Speed to bolster.

On May 6, 2025, FDA announced that it planned to conduct more surprise inspections at foreign manufacturing facilities that produce foods, essential medicines, and other medical products intended for U.S. consumers.

As previewed by former CDER Director Tidmarsh at the Consumer Healthcare Products Association meeting in September, FDA announced last week its intent to schedule a public meeting...